Header Logo

Connection

YUE LU to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications YUE LU has written about Imatinib Mesylate.
YUE LU
Connection Strength
0.018
Imatinib Mesylate
  1. Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One. 2011; 6(7):e22110.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.